Clinical Trial

The LUCENT Study - LUng Lesion Assessment Via BF-UCP190F for Central and Extended Nodal Targeting

Study acronym: LUCENT
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The Olympus BF-UCP190F bronchoscope combines the reach of a thinner bronchoscope with the benefit of real-time ultrasound, enabling direct lesion visualization and sampling deeper into the lung. Following promising first-in-human data, the LUCENT study aims to evaluate the utility feasibility, effectiveness and safety of this device in a multicenter setting, generating real-world evidence to inform broader adoption in global markets.
Trial Details
NCT Number NCT07253727
Lead Sponsor Olympus Europe SE & Co. KG
Collaborators: Heidelberg University, Lung Clinic Hemer
Conditions Bronchoscopy
Enrollment 200 participants
Start Date 2025-12-01
Primary Completion 2027-01-31 (estimated)
Study Completion 2028-08-31 (estimated)
Updated on ClinicalTrials.gov 2025-11-28